Two Sigma Investments, LP Connect Biopharma Holdings LTD Transaction History
Two Sigma Investments, LP
- $40.3 Billion
- Q1 2024
A detailed history of Two Sigma Investments, LP transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Two Sigma Investments, LP holds 10,805 shares of CNTB stock, worth $19,340. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,805
Previous 11,405
5.26%
Holding current value
$19,340
Previous $13,000
38.46%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CNTB
# of Institutions
13Shares Held
3.95MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.06MShares$3.69 Million2.4% of portfolio
-
Black Rock Inc. New York, NY1.04MShares$1.86 Million0.0% of portfolio
-
Ubs Oconnor LLC Chicago, IL511KShares$914,1540.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny240KShares$429,4210.0% of portfolio
-
Geode Capital Management, LLC Boston, MA28KShares$50,0500.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $98.5M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...